Revised SPC: Equasym XL (methylphenidate) Capsules
SPC details data from use in pregnancy from a cohort study in 3,400 patients which found a small increased risk of congenital cardiac malformations. It advises that treatment is not recommended during pregnancy unless postponing treatment may pose a greater risk to the pregnancy.
Source:
electronic Medicines compendium